ロード中...
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience
BACKGROUND: FOLFIRINOX has been shown to significantly increase both overall survival (OS) and progression-free survival (PFS) in metastatic pancreas cancer. There is limited data regarding the treatment of locally advanced pancreatic cancer. We present a retrospective study of patients with both lo...
保存先:
出版年: | Br J Cancer |
---|---|
主要な著者: | , , , , , , , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Nature Publishing Group
2016
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5023770/ https://ncbi.nlm.nih.gov/pubmed/27467054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.222 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|